Paul DiMuzio

Thomas Jefferson University, Jefferson Hospital

Papers

3

Total Citations

322

H-Index

2

About

Paul DiMuzio is a leading vascular surgeon and researcher whose work has fundamentally shaped the understanding and treatment of Median Arcuate Ligament (MAL) syndrome, a rare and often debilitating condition caused by compression of the celiac artery. His landmark review, "Median Arcuate Ligament Syndrome—Review of This Rare Disease" (2016), stands as the most-cited resource in the field with 295 citations, providing a definitive framework for diagnosis and therapeutic intervention. DiMuzio pioneered the application of robotic-assisted surgery for this condition, demonstrating through his 2012 study (25 citations) that minimally invasive techniques could offer patients safer, more effective outcomes than traditional open surgery. His contributions have transformed MAL syndrome from a poorly understood rarity into a manageable condition, establishing new standards for both diagnostic workup and surgical treatment. By combining rigorous clinical research with innovative surgical approaches, DiMuzio has become the foremost authority on this disease, directly improving outcomes for patients worldwide and inspiring a new generation of vascular surgeons to embrace robotic-assisted techniques.

Research Focus

Key Achievements

2
H-Index
3
Papers
322
Total Citations
107
Avg Citations/Paper
🏆 Most Cited Paper
Median Arcuate Ligament Syndrome—Review of This Rare Disease
295 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Thomas Jefferson University, Jefferson Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago